{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:30:16Z","timestamp":1791840616320,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Mov Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40734-017-0056-0","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T07:24:33Z","timestamp":1492759473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Functional neuroimaging and chorea: a systematic review"],"prefix":"10.1186","volume":"4","author":[{"given":"Debra J.","family":"Ehrlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth H.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"issue":"2","key":"56_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11910-014-0514-0","volume":"15","author":"A Hermann","year":"2015","unstructured":"Hermann A, Walker RH. Diagnosis and treatment of chorea syndromes. Curr Neurol Neurosci Rep. 2015;15(2):514.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"56_CR2","first-page":"1591","volume":"42","author":"A Feigin","year":"2001","unstructured":"Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, et al. Metabolic network abnormalities in early Huntington\u2019s disease: an [(18)F]FDG PET study. J Nucl Med. 2001;42(11):1591\u20135.","journal-title":"J Nucl Med"},{"issue":"3","key":"56_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"AB Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, et al. PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986;20(3):296\u2013303.","journal-title":"Ann Neurol"},{"issue":"5","key":"56_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.410120504","volume":"12","author":"DE Kuhl","year":"1982","unstructured":"Kuhl DE, Phelps ME, Markham CH, Metter EJ, Riege WH, Winter J. Cerebral metabolism and atrophy in Huntington\u2019s disease determined by 18FDG and computed tomographic scan. Ann Neurol. 1982;12(5):425\u201334.","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"56_CR5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain. 1996;119(Pt 6):2085\u201395.","journal-title":"Brain"},{"issue":"7","key":"56_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00415-014-7350-7","volume":"261","author":"M Herben-Dekker","year":"2014","unstructured":"Herben-Dekker M, van Oostrom JC, Roos RA, Jurgens CK, Witjes-Ane MN, Kremer HP, et al. Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington\u2019s disease. J Neurol. 2014;261(7):1387\u201397.","journal-title":"J Neurol"},{"issue":"9","key":"56_CR7","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1172\/JCI69411","volume":"123","author":"CC Tang","year":"2013","unstructured":"Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, et al. Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease. J Clin Invest. 2013;123(9):4076\u201388.","journal-title":"J Clin Invest"},{"issue":"6","key":"56_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","volume":"39","author":"A Ciarmiello","year":"2012","unstructured":"Ciarmiello A, Giovacchini G, Orobello S, Bruselli L, Elifani F, Squitieri F. 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging. 2012;39(6):1030\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Pt 12","key":"56_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, et al. Huntington\u2019s disease progression. PET and clinical observations. Brain. 1999;122(Pt 12):2353\u201363.","journal-title":"Brain"},{"issue":"2","key":"56_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","volume":"16","author":"JC Oostrom van","year":"2009","unstructured":"van Oostrom JC, Dekker M, Willemsen AT, de Jong BM, Roos RA, Leenders KL. Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington\u2019s disease. Eur J Neurol. 2009;16(2):226\u201331.","journal-title":"Eur J Neurol"},{"issue":"Pt 11","key":"56_CR11","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/brain\/awm217","volume":"130","author":"A Feigin","year":"2007","unstructured":"Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, et al. Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease. Brain. 2007;130(Pt 11):2858\u201367.","journal-title":"Brain"},{"issue":"Pt 5","key":"56_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/brain\/awg119","volume":"126","author":"N Pavese","year":"2003","unstructured":"Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a PET study. Brain. 2003;126(Pt 5):1127\u201335.","journal-title":"Brain"},{"issue":"10","key":"56_CR13","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/hbm.21134","volume":"32","author":"M Esmaeilzadeh","year":"2011","unstructured":"Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, et al. Extrastriatal dopamine D(2) receptor binding in Huntington\u2019s disease. Hum Brain Mapp. 2011;32(10):1626\u201336.","journal-title":"Hum Brain Mapp"},{"issue":"Pt 11","key":"56_CR14","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awn244","volume":"131","author":"M Politis","year":"2008","unstructured":"Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study. Brain. 2008;131(Pt 11):2860\u20139.","journal-title":"Brain"},{"issue":"4","key":"56_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","volume":"123","author":"AL Hebb","year":"2004","unstructured":"Hebb AL, Robertson HA, Denovan-Wright EM. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington\u2019s disease transgenic mice prior to the onset of motor symptoms. Neuroscience. 2004;123(4):967\u201381.","journal-title":"Neuroscience"},{"issue":"8","key":"56_CR16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2967\/jnumed.113.122895","volume":"55","author":"O Barret","year":"2014","unstructured":"Barret O, Thomae D, Tavares A, Alagille D, Papin C, Waterhouse R, et al. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654. J Nucl Med. 2014;55(8):1297\u2013304.","journal-title":"J Nucl Med"},{"issue":"12","key":"56_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","volume":"71","author":"DS Russell","year":"2014","unstructured":"Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, et al. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. JAMA Neurol. 2014;71(12):1520\u20138.","journal-title":"JAMA Neurol"},{"key":"56_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1212\/WNL.0000000000002391","volume":"86","author":"DS Russell","year":"2016","unstructured":"Russell DS, Jennings DL, Barret O, Tamagnan GD, Carroll VM, Caille F, et al. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging. Neurology. 2016;86:748\u201354.","journal-title":"Neurology"},{"issue":"12","key":"56_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/RLU.0000000000000968","volume":"40","author":"R Cui","year":"2015","unstructured":"Cui R, You H, Niu N, Li F. FDG PET brain scan demonstrated glucose hypometabolism of bilateral caudate nuclei and putamina in a patient with chorea-acanthocytosis. Clin Nucl Med. 2015;40(12):979\u201380.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"56_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/RLU.0b013e3181e05d3f","volume":"35","author":"NA Selcuk","year":"2010","unstructured":"Selcuk NA, Fenercioglu A. Reduction of glucose metabolism in basal ganglia diagnosed with FDG-PET scan: a neuroacanthocytosis case. Clin Nucl Med. 2010;35(7):557\u20138.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"56_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.39.9.1253","volume":"39","author":"RM Dubinsky","year":"1989","unstructured":"Dubinsky RM, Hallett M, Levey R, Di Chiro G. Regional brain glucose metabolism in neuroacanthocytosis. Neurology. 1989;39(9):1253\u20135.","journal-title":"Neurology"},{"issue":"2","key":"56_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.410300207","volume":"30","author":"DJ Brooks","year":"1991","unstructured":"Brooks DJ, Ibanez V, Playford ED, Sawle GV, Leigh PN, Kocen RS, et al. Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study. Ann Neurol. 1991;30(2):166\u201371.","journal-title":"Ann Neurol"},{"issue":"4","key":"56_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/mds.10361","volume":"18","author":"S Bohlega","year":"2003","unstructured":"Bohlega S, Al-Jishi A, Dobson-Stone C, Rampoldi L, Saha P, Murad H, et al. Chorea-acanthocytosis: clinical and genetic findings in three families from the Arabian peninsula. Mov Disord. 2003;18(4):403\u20137.","journal-title":"Mov Disord"},{"issue":"10","key":"56_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/mds.23052","volume":"25","author":"SA Schneider","year":"2010","unstructured":"Schneider SA, Lang AE, Moro E, Bader B, Danek A, Bhatia KP. Characteristic head drops and axial extension in advanced chorea-acanthocytosis. Mov Disord. 2010;25(10):1487\u201391.","journal-title":"Mov Disord"},{"issue":"8","key":"56_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00415-006-0492-5","volume":"254","author":"KR Muller-Vahl","year":"2007","unstructured":"Muller-Vahl KR, Berding G, Emrich HM, Peschel T. Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123)I-beta-CIT-SPECT. J Neurol. 2007;254(8):1081\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"56_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/mds.870130121","volume":"13","author":"M Tanaka","year":"1998","unstructured":"Tanaka M, Hirai S, Kondo S, Sun X, Nakagawa T, Tanaka S, et al. Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov Disord. 1998;13(1):100\u20137.","journal-title":"Mov Disord"},{"issue":"3","key":"56_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ana.76","volume":"49","author":"HH Jung","year":"2001","unstructured":"Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, et al. McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol. 2001;49(3):384\u201392.","journal-title":"Ann Neurol"},{"issue":"4","key":"56_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jnnp.70.4.517","volume":"70","author":"M Oechsner","year":"2001","unstructured":"Oechsner M, Buchert R, Beyer W, Danek A. Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis. J Neurol Neurosurg Psychiatry. 2001;70(4):517\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"56_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2967\/jnumed.111.101543","volume":"53","author":"K Brockmann","year":"2012","unstructured":"Brockmann K, Reimold M, Globas C, Hauser TK, Walter U, Machulla HJ, et al. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17. J Nucl Med. 2012;53(7):1074\u201380.","journal-title":"J Nucl Med"},{"issue":"3","key":"56_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.20609","volume":"58","author":"M Minnerop","year":"2005","unstructured":"Minnerop M, Joe A, Lutz M, Bauer P, Urbach H, Helmstaedter C, et al. Putamen dopamine transporter and glucose metabolism are reduced in SCA17. Ann Neurol. 2005;58(3):490\u20131.","journal-title":"Ann Neurol"},{"issue":"1","key":"56_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mds.870010105","volume":"1","author":"O Suchowersky","year":"1986","unstructured":"Suchowersky O, Hayden MR, Martin WR, Stoessl AJ, Hildebrand AM, Pate BD. Cerebral metabolism of glucose in benign hereditary chorea. Mov Disord. 1986;1(1):33\u201344.","journal-title":"Mov Disord"},{"issue":"1","key":"56_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00415-012-6618-z","volume":"260","author":"T Konishi","year":"2013","unstructured":"Konishi T, Kono S, Fujimoto M, Terada T, Matsushita K, Ouchi Y, et al. Benign hereditary chorea: dopaminergic brain imaging in patients with a novel intronic NKX2.1 gene mutation. J Neurol. 2013;260(1):207\u201313.","journal-title":"J Neurol"},{"issue":"10","key":"56_CR33","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/mds.20577","volume":"20","author":"G Kleiner-Fisman","year":"2005","unstructured":"Kleiner-Fisman G, Calingasan NY, Putt M, Chen J, Beal MF, Lang AE. Alterations of striatal neurons in benign hereditary chorea. Mov Disord. 2005;20(10):1353\u20137.","journal-title":"Mov Disord"},{"issue":"10","key":"56_CR34","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/jnnp.50.10.1284","volume":"50","author":"S Hosokawa","year":"1987","unstructured":"Hosokawa S, Ichiya Y, Kuwabara Y, Ayabe Z, Mitsuo K, Goto I, et al. Positron emission tomography in cases of chorea with different underlying diseases. J Neurol Neurosurg Psychiatry. 1987;50(10):1284\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"56_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/mds.870080404","volume":"8","author":"A Weindl","year":"1993","unstructured":"Weindl A, Kuwert T, Leenders KL, Poremba M, Grafin von Einsiedel H, Antonini A, et al. Increased striatal glucose consumption in Sydenham\u2019s chorea. Mov Disord. 1993;8(4):437\u201344.","journal-title":"Mov Disord"},{"issue":"3","key":"56_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/mds.870080318","volume":"8","author":"S Goldman","year":"1993","unstructured":"Goldman S, Amrom D, Szliwowski HB, Detemmerman D, Goldman S, Bidaut LM, et al. Reversible striatal hypermetabolism in a case of Sydenham\u2019s chorea. Mov Disord. 1993;8(3):355\u20138.","journal-title":"Mov Disord"},{"issue":"5","key":"56_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neurad.2010.10.002","volume":"38","author":"B Paghera","year":"2011","unstructured":"Paghera B, Caobelli F, Giubbini R, Premi E, Padovani A. Reversible striatal hypermetabolism in a case of rare adult-onset Sydenham chorea on two sequential 18F-FDG PET studies. J Neuroradiol. 2011;38(5):325\u20136.","journal-title":"J Neuroradiol"},{"issue":"10","key":"56_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1177\/08830738050200101101","volume":"20","author":"AM Aron","year":"2005","unstructured":"Aron AM. Sydenham\u2019s chorea: positron emission tomographic (PET) scan studies. J Child Neurol. 2005;20(10):832\u20133.","journal-title":"J Child Neurol"},{"issue":"11","key":"56_CR39","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1007\/s00415-011-6069-y","volume":"258","author":"HC Huang","year":"2011","unstructured":"Huang HC, Wu YC, Shih LY, Lo WC, Tsai CH, Shyu WC. Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea. J Neurol. 2011;258(11):2054\u20137.","journal-title":"J Neurol"},{"issue":"1","key":"56_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mds.870130127","volume":"13","author":"J Sunden-Cullberg","year":"1998","unstructured":"Sunden-Cullberg J, Tedroff J, Aquilonius SM. Reversible chorea in primary antiphospholipid syndrome. Mov Disord. 1998;13(1):147\u20139.","journal-title":"Mov Disord"},{"issue":"5","key":"56_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1179\/acb.2010.075","volume":"65","author":"J Demonty","year":"2010","unstructured":"Demonty J, Gonce M, Ribai P, Verellen-Dumoulin C, Hustinx R. Chorea associated with anti-phospholipid antibodies: case report. Acta Clin Belg. 2010;65(5):350\u20133.","journal-title":"Acta Clin Belg"},{"issue":"1","key":"56_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clineuro.2012.04.031","volume":"115","author":"EJ Chung","year":"2013","unstructured":"Chung EJ, Bae SK, Kim SJ. Generalized chorea with abnormal 18F-fluorodeoxyglucose positron emission tomography findings in a patient with hyperthyroidism. Clin Neurol Neurosurg. 2013;115(1):108\u20139.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"56_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/RLU.0b013e3180a1acb0","volume":"32","author":"BD Nguyen","year":"2007","unstructured":"Nguyen BD. Brain and upper extremity PET\/CT findings of hyperglycemia-induced hemiballism-hemichorea. Clin Nucl Med. 2007;32(8):643\u20135.","journal-title":"Clin Nucl Med"},{"key":"56_CR44","doi-asserted-by":"publisher","unstructured":"Hashimoto T, Oguchi K, Takeuchi R. Change in striatal metabolism in diabetic haemichorea-haemiballism. BMJ Case Rep. 2012.","DOI":"10.1136\/bcr-2012-006405"},{"key":"56_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2047-9158-3-14","volume":"3","author":"Y Tan","year":"2014","unstructured":"Tan Y, Xin X, Xiao Q, Chen S, Cao L, Tang H. Hemiballism-hemichorea induced by ketotic hyperglycemia: case report with PET study and review of the literature. Transl Neurodegener. 2014;3:14.","journal-title":"Transl Neurodegener"},{"issue":"Suppl 2","key":"56_CR46","doi-asserted-by":"publisher","first-page":"S325","DOI":"10.1007\/s00259-005-1973-y","volume":"32","author":"CS Levin","year":"2005","unstructured":"Levin CS. Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging. 2005;32 Suppl 2:S325\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"56_CR47","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.clineuro.2010.07.014","volume":"112","author":"J Gamez","year":"2010","unstructured":"Gamez J, Lorenzo-Bosquet C, Cuberas-Borros G, Carmona F, Hernandez-Vara J, Castillo J, et al. Does reduced [(123)I]-FP-CIT binding in Huntington\u2019s disease suggest pre-synaptic dopaminergic involvement? Clin Neurol Neurosurg. 2010;112(10):870\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"56_CR48","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.parkreldis.2013.05.005","volume":"19","author":"L Kiferle","year":"2013","unstructured":"Kiferle L, Mazzucchi S, Unti E, Pesaresi I, Fabbri S, Nicoletti V, et al. Nigral involvement and nigrostriatal dysfunction in Huntington\u2019s disease: evidences from an MRI and SPECT study. Parkinsonism Relat Disord. 2013;19(9):800\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"56_CR49","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1097\/RLU.0b013e31828162cd","volume":"39","author":"J Gamez","year":"2014","unstructured":"Gamez J, Lorenzo-Bosquet C, Cuberas-Borros G, Carmona F, Badia M, Castillo J, et al. Progressive presynaptic dopaminergic deterioration in Huntington disease: a [123I]-FP-CIT SPECT two-year follow-up study. Clin Nucl Med. 2014;39(3):e227\u20138.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"56_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1552-6569.2011.00671.x","volume":"23","author":"WJ Hwang","year":"2013","unstructured":"Hwang WJ, Yao WJ. SPECT study of the nigrostriatal dopaminergic system in Huntington\u2019s disease. J Neuroimaging. 2013;23(2):192\u20136.","journal-title":"J Neuroimaging"},{"issue":"11","key":"56_CR51","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1007\/s002590050479","volume":"26","author":"WD Leslie","year":"1999","unstructured":"Leslie WD, Greenberg CR, Abrams DN, Hobson D. Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography. Eur J Nucl Med. 1999;26(11):1458\u201364.","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"56_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00006231-200201000-00004","volume":"23","author":"NC Reynolds Jr","year":"2002","unstructured":"Reynolds Jr NC, Hellman RS, Tikofsky RS, Prost RW, Mark LP, Elejalde BR, et al. Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington\u2019s disease. Nucl Med Commun. 2002;23(1):13\u20138.","journal-title":"Nucl Med Commun"},{"issue":"13","key":"56_CR53","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/mds.25224","volume":"27","author":"M Miranda","year":"2012","unstructured":"Miranda M, Jung HH, Danek A, Walker RH. The chorea of McLeod syndrome: progression to hypokinesia. Mov Disord. 2012;27(13):1701\u20132.","journal-title":"Mov Disord"},{"issue":"5","key":"56_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000327305","volume":"65","author":"V Belcastro","year":"2011","unstructured":"Belcastro V, Pierguidi L, Tambasco N, Sironi L, Sacco L, Corso A, et al. Decreased contralateral putamen [I]FP-CIT SPECT uptake in hyperglycemic hemichorea-hemiballismus. Eur Neurol. 2011;65(5):307\u20138.","journal-title":"Eur Neurol"},{"issue":"5","key":"56_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/03009749950155535","volume":"28","author":"EB Nordal","year":"1999","unstructured":"Nordal EB, Nielsen J, Marhaug G. Chorea in juvenile primary antiphospholipid syndrome. Reversible decreased circulation in the basal ganglia visualised by single photon emission computed tomography. Scand J Rheumatol. 1999;28(5):324\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"56_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10072-008-0994-2","volume":"29","author":"W Kim","year":"2008","unstructured":"Kim W, Kim JS, Lee KS, Kim YI, Park CW, Chung YA. No evidence of perfusion abnormalities in the basal ganglia of a patient with generalized chorea-ballism and polycythaemia vera: analysis using subtraction SPECT co-registered to MRI. Neurol Sci. 2008;29(5):351\u20134.","journal-title":"Neurol Sci"},{"issue":"4","key":"56_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1590\/S0100-879X2002000400004","volume":"35","author":"OG Barsottini","year":"2002","unstructured":"Barsottini OG, Ferraz HB, Seviliano MM, Barbieri A. Brain SPECT imaging in Sydenham\u2019s chorea. Braz J Med Biol Res. 2002;35(4):431\u20136.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"56_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00858729","volume":"240","author":"N Heye","year":"1993","unstructured":"Heye N, Jergas M, Hotzinger H, Farahati J, Pohlau D, Przuntek H. Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol. 1993;240(2):121\u20133.","journal-title":"J Neurol"},{"issue":"2","key":"56_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1001\/archneur.56.2.237","volume":"56","author":"PH Lee","year":"1999","unstructured":"Lee PH, Nam HS, Lee KY, Lee BI, Lee JD. Serial brain SPECT images in a case of Sydenham chorea. Arch Neurol. 1999;56(2):237\u201340.","journal-title":"Arch Neurol"},{"issue":"4","key":"56_CR60","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1442-200x.2004.01909.x","volume":"46","author":"K Demiroren","year":"2004","unstructured":"Demiroren K, Tastekin G, Oran B. Diagnostic role of 99mTc hexamethyl-propyleneamine oxime brain single photon emission computed tomography in Sydenham\u2019s chorea. Pediatr Int. 2004;46(4):450\u20135.","journal-title":"Pediatr Int"},{"issue":"2","key":"56_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mds.25721","volume":"29","author":"R Beato","year":"2014","unstructured":"Beato R, Siqueira CF, Marroni BJ, Boanova LG, de Lima CF, Maia DP, et al. Brain SPECT in Sydenham\u2019s chorea in remission. Mov Disord. 2014;29(2):256\u20138.","journal-title":"Mov Disord"},{"issue":"3","key":"56_CR62","first-page":"369 e1\u2013e3","volume":"27","author":"JH Yu","year":"2009","unstructured":"Yu JH, Weng YM. Acute chorea as a presentation of Graves disease: case report and review. Am J Emerg Med. 2009;27(3):369 e1\u2013e3.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"56_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/jnnp.72.3.329","volume":"72","author":"JS Kim","year":"2002","unstructured":"Kim JS, Lee KS, Lee KH, Kim YI, Kim BS, Chung YA, et al. Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT. J Neurol Neurosurg Psychiatry. 2002;72(3):329\u201333.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"56_CR64","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","volume":"258","author":"SJ Bogaard van den","year":"2011","unstructured":"van den Bogaard SJ, Dumas EM, Teeuwisse WM, Kan HE, Webb A, Roos RA, et al. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington\u2019s disease provides in vivo evidence for impaired energy metabolism. J Neurol. 2011;258(12):2230\u20139.","journal-title":"J Neurol"},{"issue":"19","key":"56_CR65","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 2010;75(19):1702\u201310.","journal-title":"Neurology"},{"issue":"7","key":"56_CR66","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/mds.25010","volume":"27","author":"PG Unschuld","year":"2012","unstructured":"Unschuld PG, Edden RA, Carass A, Liu X, Shanahan M, Wang X, et al. Brain metabolite alterations and cognitive dysfunction in early Huntington\u2019s disease. Mov Disord. 2012;27(7):895\u2013902.","journal-title":"Mov Disord"},{"issue":"1","key":"56_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hbm.22616","volume":"36","author":"OF Odish","year":"2015","unstructured":"Odish OF, van den Berg-Huysmans AA, van den Bogaard SJ, Dumas EM, Hart EP, Rombouts SA, et al. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington\u2019s disease gene carriers: a three-year follow-up study. Hum Brain Mapp. 2015;36(1):110\u20139.","journal-title":"Hum Brain Mapp"},{"issue":"15","key":"56_CR68","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1017\/S0033291714000579","volume":"44","author":"RC Wolf","year":"2014","unstructured":"Wolf RC, Sambataro F, Vasic N, Depping MS, Thomann PA, Landwehrmeyer GB, et al. Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington\u2019s disease. Psychol Med. 2014;44(15):3341\u201356.","journal-title":"Psychol Med"},{"key":"56_CR69","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nicl.2013.03.001","volume":"2","author":"EM Dumas","year":"2013","unstructured":"Dumas EM, van den Bogaard SJ, Hart EP, Soeter RP, van Buchem MA, van der Grond J, et al. Reduced functional brain connectivity prior to and after disease onset in Huntington\u2019s disease. Neuroimage Clin. 2013;2:377\u201384.","journal-title":"Neuroimage Clin"},{"issue":"2","key":"56_CR70","first-page":"87","volume":"39","author":"GR Poudel","year":"2014","unstructured":"Poudel GR, Egan GF, Churchyard A, Chua P, Stout JC, Georgiou-Karistianis N. Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study. J Psychiatry Neurosci. 2014;39(2):87\u201396.","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"56_CR71","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/hbm.22351","volume":"35","author":"CJ Werner","year":"2014","unstructured":"Werner CJ, Dogan I, Sass C, Mirzazade S, Schiefer J, Shah NJ, et al. Altered resting-state connectivity in Huntington\u2019s disease. Hum Brain Mapp. 2014;35(6):2582\u201393.","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"56_CR72","doi-asserted-by":"publisher","first-page":"e72159","DOI":"10.1371\/journal.pone.0072159","volume":"8","author":"M Quarantelli","year":"2013","unstructured":"Quarantelli M, Salvatore E, Giorgio SM, Filla A, Cervo A, Russo CV, et al. Default-mode network changes in Huntington\u2019s disease: an integrated MRI study of functional connectivity and morphometry. PLoS One. 2013;8(8):e72159.","journal-title":"PLoS One"},{"issue":"9","key":"56_CR73","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/jcbfm.2011.60","volume":"31","author":"RC Wolf","year":"2011","unstructured":"Wolf RC, Gron G, Sambataro F, Vasic N, Wolf ND, Thomann PA, et al. Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington\u2019s disease. J Cereb Blood Flow Metab. 2011;31(9):1908\u201318.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"56_CR74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00001756-200204160-00033","volume":"13","author":"VP Clark","year":"2002","unstructured":"Clark VP, Lai S, Deckel AW. Altered functional MRI responses in Huntington\u2019s disease. Neuroreport. 2002;13(5):703\u20136.","journal-title":"Neuroreport"},{"issue":"1","key":"56_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pscychresns.2004.03.002","volume":"131","author":"JS Kim","year":"2004","unstructured":"Kim JS, Reading SA, Brashers-Krug T, Calhoun VD, Ross CA, Pearlson GD. Functional MRI study of a serial reaction time task in Huntington\u2019s disease. Psychiatry Res. 2004;131(1):23\u201330.","journal-title":"Psychiatry Res"},{"issue":"8","key":"56_CR76","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.neuropsychologia.2006.12.023","volume":"45","author":"N Georgiou-Karistianis","year":"2007","unstructured":"Georgiou-Karistianis N, Sritharan A, Farrow M, Cunnington R, Stout J, Bradshaw J, et al. Increased cortical recruitment in Huntington\u2019s disease using a Simon task. Neuropsychologia. 2007;45(8):1791\u2013800.","journal-title":"Neuropsychologia"},{"issue":"10","key":"56_CR77","first-page":"1715","volume":"25","author":"JS Paulsen","year":"2004","unstructured":"Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington\u2019s Disease. AJNR Am J Neuroradiol. 2004;25(10):1715\u201321.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"56_CR78","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/mds.22967","volume":"25","author":"B Zhou","year":"2010","unstructured":"Zhou B, Chen Q, Zhang Q, Chen L, Gong Q, Shang H, et al. Hyperactive putamen in patients with paroxysmal kinesigenic choreoathetosis: a resting-state functional magnetic resonance imaging study. Mov Disord. 2010;25(9):1226\u201331.","journal-title":"Mov Disord"}],"container-title":["Journal of Clinical Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40734-017-0056-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T07:25:12Z","timestamp":1492759512000},"score":1,"resource":{"primary":{"URL":"http:\/\/clinicalmovementdisorders.biomedcentral.com\/articles\/10.1186\/s40734-017-0056-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["56"],"URL":"https:\/\/doi.org\/10.1186\/s40734-017-0056-0","relation":{},"ISSN":["2054-7072"],"issn-type":[{"value":"2054-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]},"article-number":"8"}}